OCS Oculis Holding AG Ordinary shares Pharmaceutical Preparations Best Pharmaceutical Stocks 2026 →

OCS Stock Analysis: Buy, Sell, or Hold?

$7.61
+0.02 (+0.26%) ▲
5d: +4.53% 30d: -0.13% 90d: -40.64%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (90%)
Quality Score
48/100
Position
FAIR
30-Day Fair Range
$7.35 – $8.29
Position: FAIR
Forward P/E & Valuation
-5.1x
Next 12M consensus est.
Wall Street Target
$36.12
+374.7% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$6.78 / $8.84
Trend: Strong Downtrend
💡Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
â„šī¸ NEUTRAL: OCS is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.

Get Alerted When OCS Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

In-depth Analysis How we analyze

Valuation Analysis: OCS is currently trading at $7.61, which is considered fair relative to its 30-day fair value range of $7.35 to $8.29.

Technical Outlook: Technically, OCS is in a strong downtrend. Immediate support is located at $6.78, while resistance sits at $8.84.

Market Sentiment: OCS scores 63/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $36.12 (+374.7%). Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position FAIR
Historical Trading Range $7.35 - $8.29
Company Quality Score 48/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 89.6%

Trading Range & Key Levels

30-Day Trading Range $7.35 - $8.29
Current vs Trading Range FAIR
Expected Move (7 Days) Âą$0.75 (9.9%)
Support Level $6.78
Resistance Level $8.84
Current Trend Strong Downtrend
Technical data as of Nov 11, 2026

Quantitative Signal Breakdown

  • NEUTRAL: Price in fair range
  • BULLISH: Options cheap (IV 0th percentile)
  • BULLISH: Strong technical setup (63/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading 374.7% below Wall St target ($36.12)
  • WARNING: Composite score 48/100 in the bottom quintile — this cohort historically lags the market

Fundamental Context

Forward P/E (Next Year Est.) -5.13
Wall Street Target $36.12 (+374.7%)
Revenue Growth (YoY) -97.1%
Share OCS Analysis

Share this live OCS analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.

bloggers & journalists: you are free to use our charts with attribution.

Reddit & Retail Trader Sentiment (OCS)

Bullish 2 Retail Mentions
Reddit / WSB Comments
1
Bullish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Jun 30, 2026
Daily AI digest
AI Retail Discussion Summary: A bullish trader on StockTwits expresses satisfaction with their $OCS position after a recent price drop, indicating a positive outlook for the stock.
Key Retail Themes: bullish sentiment
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams. View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 7:44 PM ET
Data refreshes hourly during market hours. Next update: 8:44 PM
đŸ”Ĩ Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for OCS.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
BMRN
Biomarin Pharmaceutical â€Ļ
STRONG BUY
28 analysts
$91 56 HOLD
AXSM
Axsome Therapeutics Inc
STRONG BUY
22 analysts
$266 55 HOLD
INCY
Incyte Corporation
HOLD
28 analysts
$132 52 HOLD
ARGX
argenx NV ADR
STRONG BUY
23 analysts
$1147 35 SELL
BNTX
BioNTech SE
BUY
21 analysts
$114 62 BUY

Explore More Analysis & Live Quant Tools

Part A: Deep-Dive OCS Research Pages
OCS Technical Chart OCS Price Prediction OCS Intrinsic Value DCF OCS Earnings Date OCS Investment Advisor OCS Fair Price Analyzer OCS Competitors
Part B: Tradestie Flagship Market Scanners
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals